Feb 25, 2026 06:59AM

Feb 12, 2026 07:48AM

Jan 27, 2026 07:01AM

Jan 20, 2026 05:06AM

Jan 8, 2026 07:07AM

Dec 10, 2025 01:11AM

Dec 1, 2025 08:46AM Brookline Capital Markets Starts Opus Genetics (IRD) at Buy

Nov 25, 2025 03:54AM

Nov 6, 2025 07:03AM

Oct 29, 2025 06:54AM

Oct 16, 2025 07:53AM

Oct 1, 2025 06:55AM

Aug 18, 2025 08:01AM

Aug 13, 2025 06:13PM Opus Genetics, Inc. (IRD) Tops Q2 EPS by 7c

Jul 24, 2025 06:42AM

Jun 26, 2025 06:56AM

Jun 25, 2025 05:19PM

Jun 17, 2025 06:40AM

Jun 2, 2025 08:00AM

May 15, 2025 08:01AM

May 6, 2025 08:03AM Opus Genetics (IRD) Granted FDA RMAT Designation for OPGx-LCA5 Gene Therapy Candidate

Apr 11, 2025 08:54AM

Apr 8, 2025 08:01AM

Apr 8, 2025 06:56AM

Apr 1, 2025 06:51AM

Mar 21, 2025 09:12AM

Mar 19, 2025 03:57PM

Feb 26, 2025 08:04AM Opus Genetics (IRD) Announces FDA Fast Track and Enrollment Updates for Phentolamine Ophthalmic Solution 0.75% Programs

Feb 18, 2025 07:30AM

Dec 19, 2024 08:01AM

Nov 13, 2024 06:52AM

Nov 12, 2024 08:04AM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All